{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:12:12Z","timestamp":1698657132569},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,1,18]],"date-time":"2002-01-18T00:00:00Z","timestamp":1011312000000},"content-version":"vor","delay-in-days":657,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:p> <jats:bold>Abstract:<\/jats:bold> Ligand binding of UK 14,304 reveals notable species (i.e.,\nhuman\u2014rodent) and receptor\u2010subtype differences of\n\u03b1<jats:sub>2<\/jats:sub>\u2010adrenergic receptors (\u03b1<jats:sub>2<\/jats:sub>\u2010ARs). To study\nthe molecular basis of the selectivity of UK 14,304, we compared a series of\nconservative serine\u2014cysteine exchange mutants at ligand\u2010accessible\npositions in transmembrane domain 5 of the human and mouse\n\u03b1<jats:sub>2A<\/jats:sub>\u2010ARs. UK 14,304 bound with \u223c200\u2010fold higher affinity\nto the human \u03b1<jats:sub>2A<\/jats:sub>\u2010AR wild\u2010type receptor compared with the\nhuman \u03b1<jats:sub>2A<\/jats:sub>\u2010ARSer<jats:sup>201<\/jats:sup> mutant, but only an\napproximately fivefold difference was seen with the corresponding mouse\n\u03b1<jats:sub>2A<\/jats:sub>\u2010AR variant. These effects of cysteine\u2014serine\nexchanges only involved the agonist low\u2010affinity forms of the receptors, as\nthe affinity of [<jats:sup>3<\/jats:sup>H]UK 14,304 for the agonist high\u2010affinity\nreceptor populations was not influenced. The apparent affinities of a set of\neight structurally diverse \u03b1<jats:sub>2<\/jats:sub>\u2010AR ligands (six agonists and two antagonists) were not influenced significantly by the cysteine\u2014serine exchanges (except for oxymetazoline and yohimbine, with up to nine\u2010 and eightfold differences in affinity, respectively). We conclude that position 201 (a) plays a primary role in determining observed subtype\/species selectivity of UK 14,304 in competitive antagonist radioligand binding assays and (b) does not determine the subtype selectivity of chlorpromazine.<\/jats:p>","DOI":"10.1046\/j.1471-4159.2000.0741705.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:44:22Z","timestamp":1047451462000},"page":"1705-1710","source":"Crossref","is-referenced-by-count":7,"title":["Ligand Recognition of Serine\u2014Cysteine Amino Acid Exchanges in Transmembrane Domain 5 of \u03b1<sub>2<\/sub>\u2010Adrenergic Receptors by UK 14,304"],"prefix":"10.1111","volume":"74","author":[{"given":"V.","family":"Cockcroft","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Frang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pihlavisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Marjam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Scheinin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1997.1240"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm970767a"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(93)90600-8"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(96)01286-0"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"25668","DOI":"10.1016\/S0021-9258(18)35658-8","article-title":"Molecular basis for the species selectivity of the neurokinin\u20101 receptor antagonists CP\u201096,345 and RP67580.","volume":"267","author":"Fong T.M.","year":"1992","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(95)90410-I"},{"key":"e_1_2_6_9_2","first-page":"407","article-title":"Pharmacological characterization of rat \u03b12\u2010adrenergic receptors.","volume":"40","author":"Harrison J.K.","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(05)80271-2"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.11.6322"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(94)90106-6"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701229"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/38323"},{"key":"e_1_2_6_15_2","first-page":"16","article-title":"Cloning of two mouse genes encoding alpha 2\u2010adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2\u2010C10 homolog responsible for an interspecies variation in antagonist binding.","volume":"42","author":"Link R.","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(92)90129-J"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/mol.53.3.370","article-title":"Chloroethylclonidine binds irreversibly to exposed cysteines in the fifth membrane\u2010spanning domain of the human alpha2A\u2010adrenergic receptor.","volume":"53","author":"Marjam\u00e4ki A.","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm9605142"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5332.1676"},{"key":"e_1_2_6_20_2","unstructured":"PepperlD.J.&ReganJ.W.(1994)Adrenergic receptors inHandbook of Receptors and Channels(Peroutka S. J. ed) pp.45\u201378.CRC Press Boca Raton Florida."},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"17780","DOI":"10.1016\/S0021-9258(19)37112-1","article-title":"Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation.","volume":"267","author":"Pollock N.J.","year":"1992","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/S0021-9258(18)53777-7","article-title":"Molecular basis for the species selectivity of the substance P antagonist CP\u201096,345.","volume":"268","author":"Sachais B.S.","year":"1993","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.25.11578"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(92)91058-W"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1016\/S0021-9258(18)80035-7","article-title":"Identification of two serine residues involved in agonist activation of the beta\u2010adrenergic receptor.","volume":"264","author":"Strader C.D.","year":"1989","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/1.5.385"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1319"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/38316"},{"key":"e_1_2_6_29_2","first-page":"165","article-title":"Modeling and mutagenesis of the human alpha la\u2010adrenoceptor: orientation and function of transmembrane helix V sidechains.","volume":"4","author":"Wetzel J.M.","year":"1996","journal-title":"Receptors Channels"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/mol.54.2.435","article-title":"Contribution of serine residues to constitutive and agonist\u2010induced signaling via the D2S dopamine receptor: evidence for multiple, agonist\u2010specific active conformations.","volume":"54","author":"Wiens B.L.","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66010394.x"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1471-4159.2000.0741705.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1471-4159.2000.0741705.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T10:00:28Z","timestamp":1698573628000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1471-4159.2000.0741705.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1046\/j.1471-4159.2000.0741705.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0741705.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}